182 related articles for article (PubMed ID: 38181441)
1. Inorganic nanocarriers for siRNA delivery for cancer treatments.
Kandasamy G; Maity D
Biomed Mater; 2024 Jan; 19(2):. PubMed ID: 38181441
[TBL] [Abstract][Full Text] [Related]
2. Current advancements in self-assembling nanocarriers-based siRNA delivery for cancer therapy.
Kandasamy G; Maity D
Colloids Surf B Biointerfaces; 2023 Jan; 221():113002. PubMed ID: 36370645
[TBL] [Abstract][Full Text] [Related]
3. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
Varshosaz J; Taymouri S
Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
[TBL] [Abstract][Full Text] [Related]
4. Effective combination treatment of lung cancer cells by single vehicular delivery of siRNA and different anticancer drugs.
Li J; Wang Y; Xue S; Sun J; Zhang W; Hu P; Ji L; Mao Z
Int J Nanomedicine; 2016; 11():4609-4624. PubMed ID: 27695321
[TBL] [Abstract][Full Text] [Related]
5. Efficient nanocarriers of siRNA therapeutics for cancer treatment.
Subhan MA; Torchilin VP
Transl Res; 2019 Dec; 214():62-91. PubMed ID: 31369717
[TBL] [Abstract][Full Text] [Related]
6. Silencing of survivin and cyclin B1 through siRNA-loaded arginine modified calcium phosphate nanoparticles for non-small-cell lung cancer therapy.
Kara G; Parlar A; Cakmak MC; Cokol M; Denkbas EB; Bakan F
Colloids Surf B Biointerfaces; 2020 Dec; 196():111340. PubMed ID: 32956996
[TBL] [Abstract][Full Text] [Related]
7. Stealth monoolein-based nanocarriers for delivery of siRNA to cancer cells.
Oliveira AC; Raemdonck K; Martens T; Rombouts K; Simón-Vázquez R; Botelho C; Lopes I; Lúcio M; González-Fernández Á; Real Oliveira ME; Gomes AC; Braeckmans K
Acta Biomater; 2015 Oct; 25():216-29. PubMed ID: 26225736
[TBL] [Abstract][Full Text] [Related]
8. Combinational drug delivery using nanocarriers for breast cancer treatments: A review.
Olov N; Bagheri-Khoulenjani S; Mirzadeh H
J Biomed Mater Res A; 2018 Aug; 106(8):2272-2283. PubMed ID: 29577607
[TBL] [Abstract][Full Text] [Related]
9. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
10. Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies.
Amaldoss MJN; Yang JL; Koshy P; Unnikrishnan A; Sorrell CC
Drug Discov Today; 2022 Dec; 27(12):103386. PubMed ID: 36182068
[TBL] [Abstract][Full Text] [Related]
11. Non-viral nanocarriers for siRNA delivery in breast cancer.
Zhang J; Li X; Huang L
J Control Release; 2014 Sep; 190():440-50. PubMed ID: 24874288
[TBL] [Abstract][Full Text] [Related]
12. Lipid-based nanocarriers for delivery of small interfering RNA for therapeutic use.
Parashar D; Rajendran V; Shukla R; Sistla R
Eur J Pharm Sci; 2020 Jan; 142():105159. PubMed ID: 31747618
[TBL] [Abstract][Full Text] [Related]
13. Targeted Delivery of siRNA Therapeutics using Ligand Mediated Biodegradable Polymeric Nanocarriers.
Cho KS; Hong SJ; Ahn MH; Pal S; Choung PH; Sangshetti J; Arote RB
Curr Pharm Des; 2018; 24(16):1788-1800. PubMed ID: 29962332
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in delivery of drug-nucleic acid combinations for cancer treatment.
Li J; Wang Y; Zhu Y; Oupický D
J Control Release; 2013 Dec; 172(2):589-600. PubMed ID: 23624358
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
Varshosaz J; Farzan M
World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
[TBL] [Abstract][Full Text] [Related]
16. A biomimetic camouflaged metal organic framework for enhanced siRNA delivery in the tumor environment.
Tao T; Rehman SU; Xu S; Zhang J; Xia H; Guo Z; Li Z; Ma K; Wang J
J Mater Chem B; 2024 May; 12(17):4080-4096. PubMed ID: 38577851
[TBL] [Abstract][Full Text] [Related]
17. A strategy using mesoporous polymer nanospheres as nanocarriers of Bcl-2 siRNA towards breast cancer therapy.
Wu X; Zheng Y; Yang D; Chen T; Feng B; Weng J; Wang J; Zhang K; Zhang X
J Mater Chem B; 2019 Jan; 7(3):477-487. PubMed ID: 32254735
[TBL] [Abstract][Full Text] [Related]
18. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
[TBL] [Abstract][Full Text] [Related]
19. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
[TBL] [Abstract][Full Text] [Related]
20. Reduction sensitive nanocarriers mPEG-g-γ-PGA/SSBPEI@siRNA for effective targeted delivery of survivin siRNA against NSCLC.
Chen L; Wang S; Liu Q; Zhang Z; Lin S; Zheng Q; Cheng M; Li Y; Cheng C
Colloids Surf B Biointerfaces; 2020 Sep; 193():111105. PubMed ID: 32417465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]